medigraphic.com

2011, Number 5

<< Back Next >>

Rev Med Inst Mex Seguro Soc 2011; 49 (5)

A Trypanosoma cruzi infection without serologic evidence

Blum-Domínguez S, Espinoza B, Martínez-Martínez I, Maldonado-Velázquez G, Tamay-Segovia P

Language: Spanish
References: 11
Page: 537-539
PDF size: 39.27 Kb.


ABSTRACT

Trypanosoma cruzi was isolated from a 20 years male with no evidence of antibodies against this parasite until 12 months after the isolation and with no electrocardiographic alterations. The isolated sample obtained was characterized as T. cruzi I through PCR mini-exon. It had been reported cased without serologic reactivity to T. cruzi. It is the first case with lack reactivity reported in Mexico.


REFERENCES

  1. World Health Organization. Control of Chagas disease, second report of the WHO Expert Committee. World Health Organ Tech Rep Ser 2002;905:1-119. Disponible en http://whqlibdoc.who.int/trs/WHO_TRS_905.pdf

  2. Gomes ML, Galvao LM, Macedo AM, Pena SD, Chiari E. Chagas’ disease diagnosis: comparative analysis of parasitologic, molecular, and serologic methods. Am J Trop Med Hyg 1999;60(2):205-210. Disponible en http://www.ajtmh.org/content/60/2/205.long

  3. Wincker P, Bosseno MF, Britto C, Yaksic N, Cardoso MA, Morel CM, et al. High correlation between Chagas’ disease serology and PCR-based detection of Trypanosoma cruzi kinetoplast DNA in Bolivian children living in an endemic area. FEMS Microbiol Lett 1994;124(3):419-423.

  4. Castro AM, Luquetti AO, Rassi A, Rassi GG, Chiari E, Galvão LM. Blood culture and polymerase chain reaction for the diagnosis of the chronic phase of human infection with Trypanosoma cruzi. Parasitol Res 2002;88(10): 894-900.

  5. Rangel-Flores H, Sánchez B, Mendoza-Duarte J, Barnabé C, Breniere FS, Ramos C, et al. Serologic and parasitologic demonstration of Trypanosoma cruzi infections in an urban area of central Mexico: correlation with electro-cardiographic alterations. Am J Trop Med Hyg 2001;65 (6):887-895. Disponible en http://www.ajtmh.org/content/65/6/887.long

  6. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. New York, USA: Cold Spring Harbor, Cold Spring Harbor Laboratory Press; 1989.

  7. Souto RP, Fernandes O, Macedo AM, Campbell DA, Zingales B. DNA markers define two major phylogenetic lineages of Trypanosoma cruzi. Mol Biochem Parasitol 1996; 83(2):141-152.

  8. Salomone OA, Basquiera AL, Sembaj A, Aguerri AM, Reyes ME, Omelianuk M, et al. Trypanosoma cruzi in persons without serologic evidence of disease, Argentina. Emerg Infect Dis 2003;9(12):1558-1562. Disponible en http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3034320/pdf/03-0008. pdf

  9. Velasco-Castrejón O, Valdespino JL, Tapia-Conyer R, Salvatierra B, Guzmán-Bracho C, Magos C, et al. Seroepidemiología de la enfermedad de Chagas en México. Salud Publica Mex 1992;34(2):186-196.

  10. Añez N, Crisante G, Rojas A, Carrasco H, Parada H, Yépez Y, et al. Detection and significance of inapparent infection in Chagas disease in Western Venezuela. Am J Trop Med Hyg 2001;65(3):227-232. Disponible en http://www.ajtmh.org/content/65/3/227.long

  11. Bosseno MF, Barnabé C, Magallón-Gastélum E, Lozano- Kasten F, Ramsey J, Espinoza B, et al. Predominance of Trypanosoma cruzi lineage I in Mexico. J Clin Microbiol 2002;40(2):627-632. Disponible en http://www.ncbi.nlm.nih.gov/pmc/articles/PMC153397/?tool=pubmed




2020     |     www.medigraphic.com